Aetna considers electrothermal arthroscopy, also called electrothermally-assisted capsule shift or capsulorrhaphy (ETAC), of the joint capsule, ligaments, or tendons experimental, investigational, or unproven for all indications. The listed indications include shoulder instability, Bankart lesions, frozen shoulder, ligament tears and meniscal injury of the knee, partial scapholunate ligament tears, temporomandibular joint dislocation, and wrist injuries. HCPCS S2300 (arthroscopy, shoulder, with thermally-induced capsulorrhaphy) is listed as not covered for the indications in the policy.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.
01Billing team: do not bill electrothermal arthroscopy (ETAC) for the indications listed in the policy, because Aetna considers it experimental, investigational, or unproven for all indications.
02HCPCS S2300 is listed as not covered for the indications listed in the policy.
03The knee arthroscopy codes (CPT 29870 to 29887) are listed as not covered for electrothermal arthroscopy.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.